Ferox 15 ml IV Injection/Infus Injection

About Ferox 15 ml IV Injection/Infus 750 mg/15 ml

Ferox 15 ml IV Injection/Infus contains ferric carboxymaltose, an iron preparation given by injection or infusion for iron deficiency anemia in adults who cannot take or do not respond to oral iron.

There are 15 brands of Ferric Carboxymaltose listed in Bangladesh. The lowest listed price is Ferium Injection 500 mg/10 ml at ৳ 700 per unit.

What is Ferox 15 ml IV Injection/Infus 750 mg/15 ml?

Ferox 15 ml IV Injection/Infus is a parenteral iron preparation. It is used in adults with iron deficiency anemia who cannot tolerate oral iron or who have not responded well to it, and in adults with non-dialysis dependent chronic kidney disease. The active ingredient is ferric carboxymaltose, a complex of iron hydroxide and a carbohydrate polymer that releases iron to help replace body iron stores. It is given by a healthcare professional as an injection or infusion. The doctor decides the dose and course based on the patient's weight and needs.

Uses of Ferox 15 ml IV Injection/Infus

Ferox 15 ml IV Injection/Infus is used to treat iron deficiency anemia in adults who have intolerance to oral iron or have had an unsatisfactory response to oral iron. It is also used in adults with non-dialysis dependent chronic kidney disease. It is a parenteral iron preparation, meaning the iron is given directly into the body rather than by mouth.

How to use Ferox 15 ml IV Injection/Infus

Ferox 15 ml IV Injection/Infus is given by a healthcare professional as an intravenous injection or infusion. The doctor decides the dose, the number of doses, and the interval between them, taking into account the patient's weight and condition. Do not attempt to administer it yourself. Tell the doctor about any previous reactions to iron preparations before receiving it.

Side effects of Ferox 15 ml IV Injection/Infus

Side effects of Ferox 15 ml IV Injection/Infus may include nausea, vomiting, dizziness, headache, flushing, hypertension or hypotension, constipation, altered taste, itching, rash, hives, wheezing, injection site discoloration, and increased liver enzymes. Serious allergic-type reactions, including anaphylactic reactions, have been reported. The doctor monitors for such reactions during and after administration. Seek immediate medical attention if you feel unwell during or after the injection.

Safety and precautions

Ferox 15 ml IV Injection/Infus should only be given where staff and equipment for treating allergic reactions are immediately available. Tell your doctor if you have had any reaction to iron preparations or are allergic to any ingredient. It is not known if it is safe in pregnancy; pregnancy category C means animal studies showed harm to the fetus but human studies are lacking. The doctor will decide if the potential benefit justifies the risk. Breastfeeding mothers, people with other medical conditions, and those taking other medicines should ask the doctor first.

Frequently asked questions

How is Ferox 15 ml IV Injection/Infus given?

It is given by a healthcare professional as an intravenous injection or infusion. The doctor decides the dose, the number of doses, and the schedule based on your weight and condition. Do not try to use it yourself at home.

What is Ferox 15 ml IV Injection/Infus used for and what kind of medicine is it?

It is used for iron deficiency anemia in adults who cannot tolerate or do not respond to oral iron, and in some adults with chronic kidney disease. It is a parenteral iron preparation, so the iron is given directly into the body.

What does the generic name ferric carboxymaltose mean?

Ferric carboxymaltose is a complex of iron (ferric) hydroxide and a carbohydrate polymer called carboxymaltose. This complex is designed to release iron slowly after it is given into the body, helping to replace iron stores.

Who should ask a doctor before receiving Ferox 15 ml IV Injection/Infus?

Anyone with a known allergy to iron preparations or any ingredient should tell the doctor. Pregnant or breastfeeding women, and people with other medical conditions or on other medicines, should ask the doctor first. Only a healthcare professional can decide if it is suitable.

Indications

Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-
  • Who have intolerance to oral iron or have had unsatisfactory response to oral iron
  • Who have non-dialysis dependent chronic kidney disease.

Pharmacology

Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.

Dosage & Administration

For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.

For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.

The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.

Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.

When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.

Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.

Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.

Interaction

There are no known drug interactions and none well documented.

Contraindications

Hypersensitivity to any of its components.

Side Effects

Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactions

Pregnancy & Lactation

Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Precautions & Warnings

Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.

Hypertension: 
Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.

Storage Conditions

Do not store above 30°C. Do not freeze.

Alternative brands of Ferric Carboxymaltose

Other brands with the same generic name, cheapest first.

See all 15 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.